UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 --------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) of the SECURITIES EXCHANGE ACT OF 1934 Date of earliest event reported: May 17, 2004 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in charter) Pennsylvania 1-8036 23-1210010 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 101 Gordon Drive, P.O. Box 645, Lionville, Pennsylvania 19341-0645 (Address of Principal Executive Offices) (Zip Code) (610) 594-2900 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report) - -------------------------------------------------------------------------------- Item 5. Other Events and Regulation FD Disclosure. On May 17, 2004 West Pharmaceutical Services, Inc. (the "Company") entered into a $125 million dollar revolving credit facility with a consortium of banks. A copy of the Credit Agreement is attached hereto as Exhibit 99.1. A copy of the press release announcing the financing is attached hereto as Exhibit 99.2 and is incorporated herein by reference. Item 7. Financial Statements and Exhibits. (c) Exhibits: Exhibit List Index on page 4 of this report SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. WEST PHARMACEUTICAL SERVICES, INC. Date: May 28, 2004 By: /s/J.R.Gailey ------------------------------- Name: John R. Gailey III title: Vice President
West Pharmaceutical Services (WST) 8-KOther events
Filed: 28 May 04, 12:00am